Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis

Journal of the Neurological Sciences

Volumn 287, Issue 1-2, 2009, Pages 257-259

  Bolat, Seza ^a   Berding, Georg ^a   Dengler, Reinhard ^a   Stangel, Martin ^a   Trebst, Corinna ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Differential diagnosis; FDG PET; Neurosarcoidosis

Indexed keywords

AZATHIOPRINE; DIPEPTIDYL CARBOXYPEPTIDASE; FLUORODEOXYGLUCOSE; GADOLINIUM; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; STEROID;

ADULT; ARTICLE; ATAXIA; BLOOD LEVEL; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; ENCEPHALOMYELITIS; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERMETABOLISM; LIMB WEAKNESS; LYMPH NODE BIOPSY; LYMPHOCYTE; MALE; MEDIASTINUM LYMPH NODE; NECK PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; PARESTHESIA; PLEOCYTOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOIDOSIS; SPINAL CORD TRANSVERSE LESION; TREATMENT RESPONSE; WHOLE BODY IMAGING;

ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; DIAGNOSIS, DIFFERENTIAL; ENCEPHALITIS; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELITIS, TRANSVERSE; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; SPINAL CORD; STEROIDS; TEMPORAL LOBE; TREATMENT OUTCOME;

EID: 70350620448     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.08.060     Document Type: Article

References (12)

1. Zajicek J.P., Scolding N.J., Foster O., Rovaris M., Evanson J., Moseley I.F., et al. Central nervous system sarcoidosis diagnosis and management. QJM 92 (1999) 103-117
2. Costabel U. Sarcoidosis: clinical update. Eur Respir J 18 32 (2001) 56-68
3. Stern B.J., Krumholz A., Johns C., Scott P., and Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol 42 (1985) 909-917
4. Hoitsma E., Faber C.G., Drent M., and Sharma O.P. Neurosarcoidosis: a clinical dilemma. Lancet Neurol 3 (2004) 397-407
5. Smith J.K., Matheus M.G., and Castillo M. Imaging manifestations of neurosarcoidosis. AJR Am J Roentgenol 182 (2004) 289-295
6. Joseph F.G., and Scolding N.J. Neurosarcoidosis: a study of 30 new cases. J Neurol Neurosurg Psychiatry 80 (2009) 297-304
7. Dubey N., Miletich R.S., Wasay M., Mechtler L.L., and Bakshi R. Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis. J Neurol Sci 205 (2002) 77-81
8. 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 47 (2006) 1571-1576
9. 18F]-FDG PET and early metabolic response to corticosteroid therapy. Br J Radiol 80 (2007) e67-e71
10. 18F]fluoro-D-glucose PET metabolic response after corticosteroid therapy to differentiate cancer from sarcoidosis and sarcoid-like lesions. Mol Imaging Biol 11 (2009) 224-228
11. Zhuang H., Yu J.Q., and Alavi A. Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am 43 (2005) 121-134
12. Mana J. Magnetic resonance imaging and nuclear imaging in sarcoidosis. Curr Opin Pulm Med 8 (2002) 457-463